Haemonetics (HAE) total debt

Total debt · fiscal 2026
$1.22B

Haemonetics (HAE) carried total debt of $1.22B at the end of fiscal 2026 (March 31, 2026). That is level with fiscal 2025. Figures as of 18 Nov 2026, 06:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2026
$1.22B
Change on fiscal 2025
−0.0%
Growth, 5 years
+11.6% a year
Growth, 10 years
+11.6% a year
Highest on record
$1.22Bfiscal 2025
Lowest on record
$3.77Mfiscal 2012
Fiscal years on record
172010–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Haemonetics total debt, in more detail

Over the five fiscal years to 2026 total debt grew at a compound 11.6% a year; over ten years the rate was 11.6% a year. Across the 17 fiscal years on record (2010–2026), the highest was $1.22B in fiscal 2025 and the lowest $3.77M in fiscal 2012.

Total debt was 1.5× shareholders' equity at the end of fiscal 2026.

History · 17 fiscal years

Total debt by fiscal year

Haemonetics total debt, year by year

Haemonetics (HAE) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2026$1.22B 0.0% down1.5×
2025$1.22B 51.6% up1.5×
2024$807.79M 5.5% up0.8×
2023$765.89M 1.0% down0.9×
2022$773.59M 9.3% up1.0×
2021$707.61M 85.0% up1.0×
2020$382.49M 9.2% up0.7×
2019$350.12M 38.0% up0.5×
2018$253.68M 19.7% down0.3×
2017$315.81M 22.7% down0.4×
2016$408.47M 5.1% down0.6×
2015$430.48M 2.2% down0.5×
2014$440.29M 9.3% down0.5×
2013$485.69M 12,779.7% up0.6×
2012$3.77M 22.7% down0.0×
2011$4.88M 76.2% down0.0×
2010$20.52M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Haemonetics and comparable companies
CompanyTotal debtFiscal year
Hims & Hers Health HIMS$1.12B2025
PTC Therapeutics PTCT$2.71B2025
Haemonetics HAE$1.22B2026
Erasca ERAS$47.14M2025
Concentra Group Holdings Parent CON$2.10B2025
Merit Medical Systems MMSI$821.57M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics total debt: questions and answers

How much debt does Haemonetics have?

Haemonetics (HAE) carried total debt of $1.22B at the end of fiscal 2026 (March 31, 2026). That is level with fiscal 2025.

What is the growth rate of Haemonetics's total debt?

Over the five fiscal years to 2026 total debt grew at a compound 11.6% a year; over ten years the rate was 11.6% a year.

What are the highest and lowest total debt figures on record for Haemonetics?

Across the 17 fiscal years on record (2010–2026), the highest was $1.22B in fiscal 2025 and the lowest $3.77M in fiscal 2012.

How does Haemonetics's debt compare with its equity?

Total debt was 1.5× shareholders' equity at the end of fiscal 2026.

How is Haemonetics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/HAE/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.